Denmark
· Delayed Price · Currency is DKK Stenocare Statistics
Total Valuation
Stenocare has a market cap or net worth of DKK 8.27 million. The enterprise value is 10.62 million.
| Market Cap | 8.27M |
| Enterprise Value | 10.62M |
Important Dates
The next estimated earnings date is Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Stenocare has 19.98 million shares outstanding. The number of shares has increased by 38.18% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.98M |
| Shares Change (YoY) | +38.18% |
| Shares Change (QoQ) | +6.44% |
| Owned by Insiders (%) | 8.37% |
| Owned by Institutions (%) | n/a |
| Float | 9.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.57 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.31 |
| EV / Sales | 4.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.48 |
Financial Position
The company has a current ratio of 0.25
| Current Ratio | 0.25 |
| Quick Ratio | 0.20 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.52 |
| Interest Coverage | -13.05 |
Financial Efficiency
Return on equity (ROE) is -308.64% and return on invested capital (ROIC) is -67.89%.
| Return on Equity (ROE) | -308.64% |
| Return on Assets (ROA) | -43.50% |
| Return on Invested Capital (ROIC) | -67.89% |
| Return on Capital Employed (ROCE) | 1,979.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.08 |
| Inventory Turnover | 41.93 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.16% in the last 52 weeks. The beta is 0.13, so Stenocare's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -95.16% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 1.89 |
| Relative Strength Index (RSI) | 45.11 |
| Average Volume (20 Days) | 131,866 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Stenocare had revenue of DKK 2.23 million and -34.49 million in losses. Loss per share was -1.79.
| Revenue | 2.23M |
| Gross Profit | -5.42M |
| Operating Income | -20.04M |
| Pretax Income | -34.60M |
| Net Income | -34.49M |
| EBITDA | -11.18M |
| EBIT | -20.04M |
| Loss Per Share | -1.79 |
Balance Sheet
The company has 1.38 million in cash and 3.73 million in debt, giving a net cash position of -2.35 million or -0.12 per share.
| Cash & Cash Equivalents | 1.38M |
| Total Debt | 3.73M |
| Net Cash | -2.35M |
| Net Cash Per Share | -0.12 |
| Equity (Book Value) | -3.47M |
| Book Value Per Share | -0.17 |
| Working Capital | -15.45M |
Cash Flow
In the last 12 months, operating cash flow was -7.14 million and capital expenditures -44,413, giving a free cash flow of -7.19 million.
| Operating Cash Flow | -7.14M |
| Capital Expenditures | -44,413 |
| Free Cash Flow | -7.19M |
| FCF Per Share | -0.36 |
Margins
| Gross Margin | -243.00% |
| Operating Margin | -897.88% |
| Pretax Margin | -1,549.92% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Stenocare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.18% |
| Shareholder Yield | -38.18% |
| Earnings Yield | -416.95% |
| FCF Yield | -86.87% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Stenocare has an Altman Z-Score of -2.88. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.88 |
| Piotroski F-Score | n/a |